From Concept to Potential Therapeutics: Neuroprotective Peptides
Author:
Gozes I.,Tiong J.
Reference95 articles.
1. Alcalay RN, Giladi E, Pick CG, Gozes I. 2004. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Neurosci Lett 361: 128–131.
2. Ashur-Fabian O, Perl O, Lilling G, Fridkin M, Gozes I. 1999. SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival. Peptides 20: 629–633.
3. Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, et al. 2003. The neuroprotective peptide NAP inhibits the aggregation of the β-amyloid peptide. Peptides 24: 1413–1423.
4. Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, et al. 1999. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72: 1283–1293.
5. Bassan M, Zamostiano R, Giladi E, Davidson A, Wollman Y, et al. 1998. The identification of secreted heat shock 60-like protein from rat glial cells and a human neuroblastoma cell line. Neurosci Lett 250: 37–40.